Results 51 to 60 of about 1,472 (192)

Correlation between large FBN1 deletions and severe cardiovascular phenotype in Marfan syndrome: Analysis of two novel cases and analytical review of the literature

Molecular Genetics &Genomic Medicine, Volume 11, Issue 7, July 2023., 2023
Cardiovascular manifestation is a known phenomenon among Marfan patients. Several genotype–phenotype studies have been performed to find association between cardiovascular disease severity and FBN1 gene mutations. However, these studies focused on intragenic small‐scale mutations, and until now no study was performed to explore the connection between ...
Gergely Buki, Renata Szalai, Adrienn Pinter, Kinga Hadzsiev, Bela Melegh, Tibor Rauch, Judit Bene   +6 more
wiley   +1 more source

Utility of whole‐exome sequencing for patients with multiple congenital anomalies with or without intellectual disability/developmental delay in East Asia population

Molecular Genetics &Genomic Medicine, Volume 11, Issue 6, June 2023., 2023
Abstract Background Congenital anomalies (CAs) with or without intellectual disability (ID)/developmental delay (DD) comprise a heterogeneous spectrum of diseases that affect approximately 3% of live births worldwide. Recently, whole‐exome sequencing (WES) demonstrated the highly heterogeneous genetic causes of CAs.
Rai‐Hseng Hsu, Chen‐Hao Lee, Yin‐Hsiu Chien, Shuan‐Pei Lin, Miao‐Zi Hung, Nai‐Chi Chen, Yi‐Lin Lin, Wuh‐Liang Hwu, Ni‐Chung Lee   +8 more
wiley   +1 more source

Nosology of genetic skeletal disorders: 2023 revision

American Journal of Medical Genetics Part A, Volume 191, Issue 5, Page 1164-1209, May 2023., 2023
Abstract The “Nosology of genetic skeletal disorders” has undergone its 11th revision and now contains 771 entries associated with 552 genes reflecting advances in molecular delineation of new disorders thanks to advances in DNA sequencing technology.
Sheila Unger, Carlos R. Ferreira, Geert R. Mortier, Houda Ali, Débora R. Bertola, Alistair Calder, Daniel H. Cohn, Valerie Cormier‐Daire, Katta M. Girisha, Christine Hall, Deborah Krakow, Outi Makitie, Stefan Mundlos, Gen Nishimura, Stephen P. Robertson, Ravi Savarirayan, David Sillence, Marleen Simon, V. Reid Sutton, Matthew L. Warman, Andrea Superti‐Furga   +20 more
wiley   +1 more source

The use of segregation analysis in interpretation of sequence variants in SMAD3: A case report

Molecular Genetics &Genomic Medicine, Volume 11, Issue 2, February 2023., 2023
Genetic testing in the diagnostic setting of familial thoracic aortic aneurysm and dissections can sometimes reveal variants of uncertain significance (VUS), where not enough informative individuals are available to perform extensive segregational analysis. In this paper, we describe two families where we uncovered two VUS in the SMAD3 gene. We present
Aleksandra Ratajska, Magnus D. Vigeland, Katrine Verena Wirgenes, Kirsten Krohg‐Sørensen, Benedicte Paus   +4 more
wiley   +1 more source

Genetic variations in relation to bleeding and pharmacodynamics of dabigatran in Chinese patients with nonvalvular atrial fibrillation: A nationwide multicentre prospective cohort study

Clinical and Translational Medicine, Volume 12, Issue 12, December 2022., 2022
Genetic variations indeed affected outcomes of dabigatran in Chinese NVAF patients. Minor allele carriers of UBASH3B rs2276408 and FBN2 rs3805625 increased bleeding risk. Seventeen identified SNP polymorphisms were associated with pharmacodynamics. Fourteen reported candidate genes were associated with bleeding and pharmacodynamics.
Qian Xiang, Qiufen Xie, Zhiyan Liu, Guangyan Mu, Hanxu Zhang, Shuang Zhou, Zhe Wang, Zining Wang, Yatong Zhang, Zinan Zhao, Dongdong Yuan, Liping Guo, Na Wang, Jing Xiang, Hongtao Song, Jianjun Sun, Jie Jiang, Yimin Cui   +17 more
wiley   +1 more source

FBN2 mutation associated with manifestations of Marfan syndrome and congenital contractural arachnodactyly. [PDF]

J Med Genet, 2004
Gupta PA, Wallis DD, Chin TO, Northrup H, Tran-Fadulu VT, Towbin JA, Milewicz DM.   +6 more
europepmc   +3 more sources

The fibrillinopathies: New insights with focus on the paradigm of opposing phenotypes for both FBN1 and FBN2

Human Mutation, Volume 43, Issue 7, Page 815-831, July 2022., 2022
The paradigm of opposing phenotypes for both FBN1 and FBN2 suggests shared pathomechanisms. Abstract Different pathogenic variants in the fibrillin‐1 gene (FBN1) cause Marfan syndrome and acromelic dysplasias. Whereas the musculoskeletal features of Marfan syndrome involve tall stature, arachnodactyly, joint hypermobility, and muscle hypoplasia ...
Silke Peeters, Pauline De Kinderen, Josephina A. N. Meester, Aline Verstraeten, Bart L. Loeys   +4 more
wiley   +1 more source

Elastic fibers: formation, function, and fate during aging and disease

The FEBS Journal, Volume 289, Issue 13, Page 3704-3730, July 2022., 2022
Elastic fibers are vital extracellular components of vertebrates providing numerous tissues and organs with the elasticity and resilience required for their function. Here, we review the current knowledge and discuss open questions on the formation, structure, and functions of elastic fibers and how aging and diseases affect their fate over the human ...
Christian E. H. Schmelzer, Laurent Duca
wiley   +1 more source

The Fibrillin‐1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells

Cancer Communications, Volume 42, Issue 3, Page 245-265, March 2022., 2022
Abstract Background Chemotherapy resistance is a primary reason of ovarian cancer therapy failure; hence it is important to investigate the underlying mechanisms of chemotherapy resistance and develop novel potential therapeutic targets. Methods RNA sequencing of cisplatin‐resistant and ‐sensitive (chemoresistant and chemosensitive, respectively ...
Ziliang Wang, Wei Chen, Ling Zuo, Midie Xu, Yong Wu, Jiami Huang, Xu Zhang, Yongheng Li, Jing Wang, Jing Chen, Husheng Wang, Huizhen Sun   +11 more
wiley   +1 more source

Perspectives on the revised Ghent criteria for the diagnosis of Marfan syndrome [PDF]

, 2015
Three international nosologies have been proposed for the diagnosis of Marfan syndrome (MFS): the Berlin nosology in 1988; the Ghent nosology in 1996 (Ghent-1); and the revised Ghent nosology in 2010 (Ghent-2).
Bannas, Peter, Behzadi, Cyrus, Bernhardt, Alexander M, Blankenberg, Stefan, De Backer, Julie, Fuisting, Bettina, Hillebrand, Mathias, Kölbel, Tilo, Püschel, Klaus, Robinson, Peter N, Rybczynski, Meike, Schüler, Helke, Sheikhzadeh, Sara, von Kodolitsch, Yskert   +13 more
core   +2 more sources